Navigation Links
Exercise Has An Anti-Cancer Effect

Australian researchers found that anti-cancer effects of exercise results from an increase in a protein called insulin-like binding// protein-3 (IGFBP-3) that blocks cell growth and cause cell death.

A study reports ‘Insulin-like binding protein-3 (IGFBP-3), which is a protein that inhibits the action of another protein called insulin-like growth factor-1 (IGF-1), blocks IGF-1’s proliferative effect on cell growth, due to which the result appears.

In the Melbourne Collaborative Cohort Study, Dr. Andrew M. M. Haydon and colleagues at Manash Medical School in Melbourne found out new cases of colorectal cancer in studying 41,528 adults during the year 1990-1994.

Analysis of 443 colon cancer patients for a period of more than 5 years were carried out for the comparison of baseline levels of IGF-1or IGFBP-3 with baseline body mass index and level of physical activity. Physically active subjects showed an increase in IGFBP-3 with a 48 percent reduction in colon cancer-specific deaths. No association was apparent for IGF-1.Physically inactive subjects showed no correlation and positive results.

Physical activity increases IGFBP-3 levels. IGFBP-3 reduces the amount of free IGF-1, which, in turn, has been shown to stimulate cell growth, inhibit cell death, and promote angio genesis (formation of new blood vessels). And this study looked dose-effect and effect of physical effect – Haydon elaborates.

'"/>




Page: 1

Related medicine news :

1. Exercises reduce risks of cancers
2. Exercise lowers Risk of Ovarian Cancer
3. Exercise is necessary in daily life
4. Exercise for patients with cancer
5. Exercise therapy for fibromyalgia
6. Exercise has a undeniable effect on cholesterol
7. Exercise with music aids with lung disorders
8. Exercise helps with leg cramps
9. Exercise helps people with cramping leg pain
10. Kids not getting enough Physical Exercise
11. Moderate Exercise may not help prevent Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/5/2016)... ... February 05, 2016 , ... At its annual meeting held last ... Chairman of the National Board of Directors. Mr. McDermott succeeds former APDA Chairman, Fred ... Leslie A. Chambers , APDA President and CEO. “Pat has tirelessly served APDA ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Stuart ... tattoo technology, the PicoSure. Designed to provide the most effective tattoo removal today, Dr. ... with unmatched results. , Developed by Cynosure, the PicoSure has been approved by the ...
(Date:2/5/2016)... ... February 05, 2016 , ... Colorize is ... one drop zone to the next using Colorize's dynamic moving camera. Colorize is perfect ... package includes a 3D slideshow environment with 1 to 5 focus points per scene, ...
(Date:2/5/2016)... , ... February 05, 2016 , ... Health and wellness ... relevant to individuals in the event they are experiencing an illness. Migraines are a ... Americans that are afflicted with migraines would not wish the pain on their worst ...
(Date:2/5/2016)... ... 2016 , ... On June 9-10, Las Vegas will host ... (CME) event presented by the Association for Comprehensive Care in Rare Diseases (ACCORD). ... mission is to provide education, tools, and resources to primary care clinicians that ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... Bernstein Liebhard LLP today announced that a securities class ... for the District of Arizona on ... or entities who purchased common shares of Insys Therapeutics Inc. ... 3, 2015 through January 25, 2016 (the "Class Period").  The ... of the Securities Exchange Act of 1934.  ...
(Date:2/4/2016)... , Feb. 4, 2016 Global Immunology ... market to drive long-term market growth Summary ... set of chronic disorders that affect 5–7% of ... terms of their symptoms and key patient demographics, ... of immune pathways and an inappropriate immune response. ...
(Date:2/4/2016)... SPRING, Md. , Feb. 4, 2016 In ... Califf , the FDA,s Deputy Commissioner for Medical Products and ... action plan to reassess the agency,s approach to opioid medications. ... epidemic, while still providing patients in pain access to effective ... The FDA will: , Re-examine the risk-benefit paradigm ...
Breaking Medicine Technology: